These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4274761)

  • 1. Ultrastructural evidence for the localization of an indolealkylamine in supra-ependymal nerves from combined cytochemistry and pharmacology.
    Richards JG; Tranzer JP
    Experientia; 1974 Mar; 30(3):287-9. PubMed ID: 4274761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indolealkylamine nerve terminals in cerebral ventricles: identification by electron microscopy and fluorescence histochemistry.
    Richards JG; Lorez HP; Tranzer JP
    Brain Res; 1973 Jul; 57(2):277-88. PubMed ID: 4352871
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of indolealkylamine nerve terminals in the ventricles of the rat brain.
    Lorez HP; Richards JG
    Z Zellforsch Mikrosk Anat; 1973 Nov; 144(4):511-22. PubMed ID: 4276268
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurochemical changes following the administration of depleters of biogenic monoamines.
    Lane JD; Smith JE; Shea PA; McBride WJ
    Life Sci; 1976 Dec; 19(11):1663-7. PubMed ID: 12434
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC; Healy MD
    Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-HT nerve terminals in the fourth ventricle of the rat brain: their identification and distribution studied by fluorescence histochemistry and electron microscopy.
    Lorez HP; Richards JG
    Cell Tissue Res; 1975 Dec; 165(1):37-48. PubMed ID: 128416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
    Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
    [No Abstract]   [Full Text] [Related]  

  • 8. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS.
    Fuxe K; Hökfelt T
    Triangle; 1971; 10(3):73-84. PubMed ID: 5138525
    [No Abstract]   [Full Text] [Related]  

  • 9. Nomifensine and central monoamine neurons: histofluorescence studies.
    Smialowska M
    Pol J Pharmacol Pharm; 1977; 29(5):509-19. PubMed ID: 145591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural and cytochemical localization of the storage sites of monoamines in the paraventricular organ of Xenopus laevis tadpoles.
    Chacko T; Peute J
    Cell Tissue Res; 1974; 151(4):417-21. PubMed ID: 4371980
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Amine depletion as an experimental approach to the aminergic hypothesis.
    Mendels J
    Psychopharmacol Bull; 1974 Oct; 10(4):54-6. PubMed ID: 4279415
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluorescence histochemistry of monoamine-containing cell bodies in the brain stem of the squirrel monkey (Saimiri sciureus). I. The locus caeruleus.
    Hubbard JE; Di Carlo V
    J Comp Neurol; 1973 Feb; 147(4):553-66. PubMed ID: 4196792
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of CNS catecholamine-depleting drugs on dextroamphetamine-induced elevation of halothane MAC.
    Johnston RR; Way WL; Miller RD
    Anesthesiology; 1974 Jul; 41(1):57-61. PubMed ID: 4275974
    [No Abstract]   [Full Text] [Related]  

  • 14. Biogenic amines and narcotic effects. I. Modification of morphine-induced analgesia and motor activity after alteration of cerebral amine levels.
    Buxbaum DM; Yarbrough GG; Carter ME
    J Pharmacol Exp Ther; 1973 May; 185(2):317-27. PubMed ID: 4267383
    [No Abstract]   [Full Text] [Related]  

  • 15. Social environment and brain biogenic amine metabolism in rats.
    Stolk JM; Conner RL; Barchas JD
    J Comp Physiol Psychol; 1974 Aug; 87(2):203-7. PubMed ID: 4279254
    [No Abstract]   [Full Text] [Related]  

  • 16. Brain monoamines and the high pressure neurological syndrome.
    Koblin DD; Little HJ; Green AR; Daniels S; Smith EB; Paton WD
    Neuropharmacology; 1980 Nov; 19(11):1031-8. PubMed ID: 6449674
    [No Abstract]   [Full Text] [Related]  

  • 17. [Brain amines and apomorphine-induced intraspecific aggressive behavior in the rat (author's transl)].
    Senault B
    Psychopharmacologia; 1974 Jan; 34(2):143-54. PubMed ID: 4274176
    [No Abstract]   [Full Text] [Related]  

  • 18. Biogenic amines and related enzymes in the circumventricular organs of the rat.
    Saavedra JM; Brownstein MJ; Kizer JS; Palkovits M
    Brain Res; 1976 May; 107(2):412-7. PubMed ID: 5177
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine and 5,7-dihydroxytryptamine on the hippocampal kindling effect in rats.
    Araki H; Aihara H; Watanabe S; Yamamoto T; Ueki S
    Jpn J Pharmacol; 1983 Dec; 33(6):1177-82. PubMed ID: 6230476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between magnitude of electroshock stimulation and the effects of digitoxigenin, pentylenetetrazol and brain monoamine reduction on electroshock convulsive thresholds.
    Buterbaugh GG; London ED
    Neuropharmacology; 1977 Sep; 16(9):617-23. PubMed ID: 144247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.